Table 5.
Frequency of anti-ENA in each group.
| Anti-ENA marker | Thyroid+ (n = 475) | Anti-TPO+ (n = 3063) | Anti-Tg+ (n = 2511) | |||
|---|---|---|---|---|---|---|
| Frequency | Percentage | Frequency | Percentage | Frequency | Percentage | |
| Histone | 275 | 57.9% | 1798 | 72.5% | 1471 | 58.6% |
| RNA POL III | 80 | 16.8% | 532 | 21.4% | 408 | 16.2% |
| Chromatin | 64 | 13.5% | 398 | 16.0% | 321 | 12.8% |
| dsDNA | 63 | 13.3% | 291 | 11.7% | 265 | 10.6% |
| Centromere | 52 | 10.9% | 332 | 13.4% | 265 | 10.6% |
| SSB (La) | 39 | 8.2% | 281 | 11.3% | 244 | 9.7% |
| SSA (Ro) | 36 | 7.6% | 199 | 8.0% | 182 | 7.2% |
| Scl-70 | 22 | 4.6% | 215 | 11.3% | 173 | 6.9% |
| Sm | 13 | 2.7% | 97 | 3.9% | 77 | 3.1% |
| RNP | 13 | 2.7% | 59 | 2.4% | 51 | 2.0% |
| Jo-1 | 12 | 2.5% | 46 | 1.9% | 44 | 1.8% |